NCLEX Review Guide: Inflammatory Bowel Disease

Definition and Pathophysiology

• Inflammatory Bowel Disease (IBD) refers to a group of chronic inflammatory disorders affecting the gastrointestinal tract, primarily including Crohn's Disease and Ulcerative Colitis. These conditions are characterized by periods of remission and exacerbation with immune system dysfunction leading to inflammation of the intestinal mucosa.
• The exact etiology remains unclear but involves a complex interaction between genetic predisposition, environmental factors, intestinal microbiota, and an abnormal immune response.

Distinguishing Features

Common Symptoms

• Diarrhea: Often bloody in UC; may be non-bloody in Crohn's. Persistent diarrhea is a hallmark symptom, with patients experiencing frequent, loose stools, often with urgency.
• Abdominal pain: Typically in right lower quadrant in Crohn's; lower abdominal cramping in UC. Pain often worsens after meals and may improve after bowel movements.
• Weight loss: More common in Crohn's due to malabsorption, reduced oral intake, and increased metabolic demand from chronic inflammation.
• Fatigue: Results from chronic inflammation, anemia, and malnutrition.
• Fever: Low-grade fever may indicate active inflammation or complications such as abscess.

Extraintestinal Manifestations

• Musculoskeletal: Arthritis (peripheral and axial), ankylosing spondylitis, sacroiliitis.
• Dermatologic: Erythema nodosum, pyoderma gangrenosum, aphthous stomatitis.
• Ocular: Episcleritis, uveitis, iritis.
• Hepatobiliary: Primary sclerosing cholangitis (more common in UC), cholelithiasis, fatty liver.

Laboratory Tests

• Complete Blood Count (CBC): May show anemia (due to chronic disease or iron deficiency from blood loss), leukocytosis (indicating inflammation or infection), and thrombocytosis (acute phase reactant).
• Inflammatory Markers: Elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) indicate active inflammation but are not specific to IBD.
• Comprehensive Metabolic Panel: May reveal hypoalbuminemia (protein loss, malnutrition), electrolyte abnormalities, and elevated liver enzymes.
• Fecal Calprotectin: A calcium and zinc-binding protein derived from neutrophils that is elevated in intestinal inflammation; useful for differentiating IBD from functional disorders and monitoring disease activity.
• Stool Studies: To rule out infectious causes of diarrhea (C. difficile, parasites, bacterial pathogens).

Imaging and Endoscopic Procedures

• Colonoscopy with Biopsy: Gold standard for diagnosis; allows direct visualization of the colon and terminal ileum, assessment of disease extent and severity, and collection of tissue samples for histopathology.
• Upper Endoscopy: May be performed in suspected Crohn's disease to evaluate upper GI tract involvement.
• Capsule Endoscopy: Useful for evaluating small bowel in Crohn's disease; contraindicated if strictures are suspected.
• CT Enterography: Provides detailed images of the small bowel and can identify complications such as fistulas, abscesses, and strictures.
• MR Enterography: Similar to CT enterography but without radiation exposure; preferred for younger patients and those requiring repeated imaging.

Medication Categories

• 5-Aminosalicylates (5-ASAs): First-line therapy for mild to moderate UC; less effective in Crohn's disease. Examples include mesalamine (Asacol, Pentasa), sulfasalazine, balsalazide, and olsalazine. These medications work topically to reduce inflammation in the intestinal mucosa.
• Corticosteroids: Used for acute flares but not for maintenance therapy due to significant side effects with long-term use. Examples include prednisone, methylprednisolone, and budesonide (has first-pass metabolism, reducing systemic effects). Never abruptly discontinue steroids; always taper to prevent adrenal crisis.
• Immunomodulators: Used for steroid-sparing effect and maintenance of remission. Examples include:
  • Thiopurines: Azathioprine and 6-mercaptopurine (6-MP) - require monitoring for myelosuppression and hepatotoxicity
  • Methotrexate - requires folate supplementation and monitoring for hepatotoxicity and pneumonitis
• Biologic Agents: Used for moderate to severe disease or when other therapies fail:
  • TNF-α inhibitors: Infliximab, adalimumab, certolizumab pegol, golimumab
  • Anti-integrin therapy: Vedolizumab
  • IL-12/23 inhibitor: Ustekinumab
  • JAK inhibitors: Tofacitinib (for UC)
• Antibiotics: Metronidazole and ciprofloxacin - primarily used in Crohn's disease for perianal disease, fistulas, and bacterial overgrowth.

Indications and Procedures

• Crohn's Disease Surgery: Not curative; reserved for complications or failure of medical therapy. Common indications include strictures causing obstruction, fistulas, abscesses, perforation, and medically refractory disease. Surgical approaches include strictureplasty, limited bowel resection with primary anastomosis, and fistula repair.
• Ulcerative Colitis Surgery: Can be curative since disease is limited to colon and rectum. Indications include medically refractory disease, dysplasia or cancer, growth retardation in children, and complications like toxic megacolon or massive hemorrhage. Surgical options include:
  • Total proctocolectomy with permanent ileostomy
  • Total proctocolectomy with ileal pouch-anal anastomosis (IPAA or J-pouch)
  • Subtotal colectomy with ileorectal anastomosis (less common)

Assessment and Interventions

• Assessment: Monitor bowel patterns (frequency, consistency, presence of blood or mucus), abdominal pain characteristics, vital signs (fever may indicate inflammation or infection), weight changes, nutritional status, hydration status, and signs of complications.
• Pain Management: Administer prescribed analgesics, assess effectiveness, monitor for opioid-induced constipation which may worsen symptoms, and teach non-pharmacological pain management techniques.
• Nutrition Management: Collaborate with dietitian to develop appropriate diet plan. During flares, patients may require low-residue or elemental diets, parenteral nutrition, or enteral nutrition (especially beneficial in Crohn's disease).
• Fluid and Electrolyte Management: Monitor for dehydration due to diarrhea; administer IV fluids as ordered; monitor electrolytes, especially potassium, magnesium, and zinc which can be depleted with chronic diarrhea.

Patient Education

1. Teach medication administration, expected effects, and potential side effects. For biologics, provide education on self-injection techniques if applicable.
2. Educate about dietary modifications: foods that may exacerbate symptoms vary by individual but often include high-fiber foods, dairy products, spicy foods, alcohol, and caffeine.
3. Instruct on importance of regular follow-up appointments and monitoring laboratory tests.
4. Discuss symptoms requiring immediate medical attention: severe abdominal pain, high fever, excessive bleeding, signs of dehydration, or medication side effects.
5. Provide information about ostomy care if applicable, including skin care, appliance changes, and management of potential complications.

Common Complications

• Intestinal Complications:
  • Strictures and obstruction (more common in Crohn's)
  • Fistulas and abscesses (characteristic of Crohn's)
  • Toxic megacolon (more common in UC)
  • Perforation
  • Hemorrhage
  • Increased risk of colorectal cancer (especially in long-standing UC)
• Nutritional Complications:
  • Malnutrition and weight loss
  • Iron deficiency anemia
  • Vitamin B12 deficiency (in Crohn's with terminal ileum involvement)
  • Vitamin D deficiency and bone demineralization
  • Growth retardation in children

Special Populations

• Pregnancy: Active disease at conception increases risk of adverse outcomes; most IBD medications are considered low risk during pregnancy and should be continued to maintain remission. Methotrexate is absolutely contraindicated in pregnancy due to teratogenicity.
• Pediatric Patients: May present with atypical symptoms; growth failure may be the primary manifestation. Treatment goals include not only symptom control but also normal growth and development, bone health, and psychosocial well-being.
• Elderly Patients: May have atypical presentations, more comorbidities, and increased risk of medication side effects. Careful monitoring for drug interactions and adverse effects is essential.

Clarifying Misconceptions

Essential Concepts for NCLEX

• Disease Comparison: Crohn's disease can affect any part of the GI tract, has transmural inflammation, skip lesions, and complications including fistulas and strictures. Ulcerative colitis is limited to the colon and rectum, has continuous inflammation limited to mucosa/submucosa, and complications including toxic megacolon and increased colorectal cancer risk.
• Clinical Manifestations: Common symptoms include diarrhea (bloody in UC, may be non-bloody in Crohn's), abdominal pain, weight loss, fatigue, and fever. Extraintestinal manifestations include arthritis, skin lesions, eye inflammation, and liver conditions.
• Treatment Approach: Medications include 5-ASAs, corticosteroids, immunomodulators, biologics, and antibiotics. Surgical interventions differ between Crohn's (not curative) and UC (potentially curative).
• Nursing Priorities: Focus on symptom management, nutrition support, medication administration and teaching, complication monitoring, and psychosocial support.

NCLEX Preparation Strategies

Quick Check Questions